Area of research
Epidemiology · Hepatology
Research interest
Research focused on Ursodeoxycholic acid and FGF19, with related work in Gene knockdown, Nonalcoholic fatty liver disease, Cell cycle. Notable publications include 'Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries', 'Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis', and 'Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis'.
Glaucocalyxin A alleviates ulcerative colitis by inhibiting PI3K/AKT/mTOR signaling
Genetically engineered bacteria expressing IL-34 alleviate DSS-induced experimental colitis by promoting tight junction protein expression in intestinal mucosal epithelial cells
Efficacy of Consistency Versus Switching of Biologics for Prevention of Postoperative Recurrence in Crohn’s Disease: A Multicenter Real-World Retrospective Study
CircGNAO1 suppresses hepatocellular carcinoma progression and metastasis via sponging miR-182-5p and regulating FOXO1 expression
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries
Construction of a ceRNA regulatory network to explore potential pathogenesis mechanisms involved in human hepatocellular carcinoma
A ferroptosis associated gene signature for predicting prognosis and immune responses in patients with colorectal carcinoma
Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression
Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice
Inhibition of Phosphoinositide 3-Kinase Gamma Protects Endothelial Cells via the Akt Signaling Pathway in Sepsis-Induced Acute Kidney Injury
Hsa_circ_0013290 Acts as Cancer-Promoting Gene in Hepatocellular Carcinoma
CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
Long Non-Coding RNA (lncRNA) NEAT1 Aggravates Cerebral Ischemia-Reperfusion Injury by Suppressing the Inhibitory Effect of miR-214 on PTEN
Mucosal-associated invariant T cells in hepatitis B virus-related liver failure
Transmembrane protein 106C promotes the development of hepatocellular carcinoma
Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis
Downregulation of nucleolar and spindle‑associated protein 1 expression suppresses liver cancer cell function
Interleukin-34 drives macrophage polarization to the M2 phenotype in autoimmune hepatitis
Correction to: Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis
Nucleolar spindle‐associated protein 1 promotes tumorigenesis and predicts poor prognosis in human esophageal squamous cell carcinoma
Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis
Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization
The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: Regulation by cholic acid-induced Interleukin-7
High NUSAP1 expression predicts poor prognosis in colon cancer
Long non-coding RNA CCAL/miR-149/FOXM1 axis promotes metastasis in gastric cancer
High expression of ubiquitin-conjugating enzyme E2A predicts poor prognosis in hepatocellular carcinoma
Upregulation of thyroid hormone receptor interactor�13 is associated with human hepatocellular carcinoma
The risk predictive values of <scp>UK</scp>‐<scp>PBC</scp> and <scp>GLOBE</scp> scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti‐gp210
Effect of NDC80 in human hepatocellular carcinoma
A functional characteristic of cysteine‐rich protein 61: Modulation of myeloid‐derived suppressor cells in liver inflammation